• December 27, 2024 – Important Update in the Valsartan MDL

    Published On: January 10, 2025|Categories: Valsartan|By |

    This week, there’s a significant development in the ongoing Valsartan multi-district litigation (MDL). The judge overseeing the case has selected five plaintiffs’ lawsuits to proceed to the next round of bellwether trials. These trials play a crucial role in advancing the litigation process. When bellwether trials result in favorable verdicts for plaintiffs, it often prompts settlement discussions in many cases, although not all cases may follow this path.

  • December 20, 2024: Federal Judge Selects 5 Valsartan Cases for Second Round of Bellwether Trials

    Published On: January 10, 2025|Categories: Valsartan|By |

    On December 16, 2024, the federal judge overseeing the Valsartan litigation confirmed the selection of five cases for the second set of bellwether trials. These trials are part of the multidistrict litigation (MDL) against the manufacturers of Valsartan, specifically addressing the harmful effects of NDMA contamination in the medication. MDL 2875 includes individuals who were harmed by the contaminated drug, and these bellwether trials will serve as important test cases, offering insights into how other lawsuits in the MDL may be resolved. As such, the outcomes of these trials hold significant implications for all plaintiffs involved in the litigation.

  • November 1, 2024 – New Bellwether Trial Scheduled Following Postponement

    Published On: January 10, 2025|Categories: Valsartan|By |

    After the postponement of the first lawsuit selected for a bellwether trial, a new case has been scheduled to kick off the trials. The first trial will now involve a lawsuit filed by an Alabama man who developed liver cancer after taking Valsartan. This case is seen as a stronger choice, as it will provide valuable insights to all plaintiffs—and potential plaintiffs—about what they can expect as the litigation progresses.

  • October 18, 2024 – Growing Interest in Valsartan MDL Ahead of First Bellwether Trial

    Published On: January 10, 2025|Categories: Valsartan|By |

    As the first bellwether trial in the Valsartan multi-district litigation (MDL) draws near, we are seeing an increase in interest surrounding the case. This is a common development, and we anticipate continued inquiries and new Valsartan claims for the foreseeable future. If you believe you may have a claim, now is the time to act. Contact us today for a free consultation to discuss your case.